The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study
Fig 1
Estimated treatment strategy associated with greatest quality-adjusted life-year gains (QALY) by patient age, sex and comorbidity groups for non-small cell lung cancer according to stage (American Joint Committee on Cancer [AJCC] 8th edition).
(A) Stage IB; (B) Stage IIA; (C) Stage IIB; (D) Stage IIIA. Congestive heart failure (CHF) refers to mild/moderate CHF.